Survey Assessment of Patient and Provider Impressions of Telemedicine in Radiation Oncology
Study Details
Study Description
Brief Summary
To understand more about the opinions of patients and health providers on the use of telemedicine in radiation oncology.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Detailed Description
Primary Objective:
To characterize patient and provider satisfaction with telemedicine in RO
Secondary Objective:
-
To provide evidence for or against the use of telemedicine in radiation oncology (RO)
-
To assess the feasibility of and value added by telemedicine in RO
-
To describe barriers and facilitators to telemedicine in RO
-
To identify preferred use cases for telemedicine in RO
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Telemedicine Visits Participants are asked to fill out a survey about their experience. |
Behavioral: Survey Administration
Patients and providers complete survey over 10 minutes about their perspectives on the use of telemedicine
|
Outcome Measures
Primary Outcome Measures
- Patient satisfaction survey with telemedicine in radiation oncology (RO) [through study completion and average of one year.]
Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers.
- Provider satisfaction survey with telemedicine in radiation oncology (RO) [through study completion and average of one year.]
Sensitivity analyses will be performed with those rating 9 or higher or less than 9, and for those who "agree" or "strongly agree" with whether they are satisfied with telemedicine compared to those who give other answers.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Patients will be eligible if they are aged 18 or older and have undergone at least 1 telemedicine encounter (video visit) with the radiation oncology department at MD Anderson or its affiliates within 2 months from the initiation of the study (and prospectively as the study enrolls). This would include weekly see visits, follow-up visits, or consultations
-
English speaking
-
Access to email and internet to complete the survey
-
Attending physicians in the radiation oncology department who have utilized telemedicine will be contacted to fill out surveys reflecting their experience
Exclusion Criteria:
• Protected populations such as adults unable to consent, pregnant women, prisoners, and individuals who are not yet adults will be excluded
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | MD Anderson Cancer Center | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- M.D. Anderson Cancer Center
Investigators
- Principal Investigator: Chenyang Wang, MD, M.D. Anderson Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 2020-1063
- NCI-2021-09908